These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27710971)

  • 21. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.
    Chen J; Sun MX; Hua YQ; Cai ZD
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1205-10. PubMed ID: 24682390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Combined Lactate Dehydrogenase, C-Reactive Protein, Cancer Antigen 153 and Cancer Antigen 125 in Metastatic Breast Cancer.
    Ma YY; Wang H; Zhao WD; Li YF; Wang JJ; Chen XY; Huang YQ; Wang WJ; Wang Y; Sun SC
    Cancer Control; 2022; 29():10732748211053150. PubMed ID: 34989251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis.
    Li X; Gu L; Chen Y; Chong Y; Wang X; Guo P; He D
    Ann Med; 2021 Dec; 53(1):1827-1838. PubMed ID: 34647517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
    Wu B; Sun C; Feng F; Ge M; Xia L
    J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis.
    Zhang X; Guo M; Fan J; Lv Z; Huang Q; Han J; Wu F; Hu G; Xu J; Jin Y
    Cancer Biomark; 2016; 16(3):415-23. PubMed ID: 27062698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score).
    Bigot F; Castanon E; Baldini C; Hollebecque A; Carmona A; Postel-Vinay S; Angevin E; Armand JP; Ribrag V; Aspeslagh S; Varga A; Bahleda R; Menis J; Gazzah A; Michot JM; Marabelle A; Soria JC; Massard C
    Eur J Cancer; 2017 Oct; 84():212-218. PubMed ID: 28826074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
    Xia Y; Wei X; Gong H; Ni Y
    BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Role of Serum Lactate Dehydrogenase in Patients With Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
    Wu M; Lin P; Xu L; Yu Z; Chen Q; Gu H; Liu C
    Front Oncol; 2020; 10():677. PubMed ID: 32509573
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: A PRISMA-compliant meta-analysis.
    Li J; Cheng Y; Ji Z
    Medicine (Baltimore); 2019 Jan; 98(2):e14091. PubMed ID: 30633220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between lactate dehydrogenase levels and oncologic outcomes in metastatic prostate cancer: A meta-analysis.
    Li F; Xiang H; Pang Z; Chen Z; Dai J; Chen S; Xu B; Zhang T
    Cancer Med; 2020 Oct; 9(19):7341-7351. PubMed ID: 32452656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactate dehydrogenase is correlated with clinical stage and grade and is downregulated by si‑SAΤB1 in ovarian cancer.
    Xiang J; Zhou L; Zhuang Y; Zhang J; Sun Y; Li S; Zhang Z; Zhang G; He Y
    Oncol Rep; 2018 Nov; 40(5):2788-2797. PubMed ID: 30132561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin.
    Armstrong AJ; George DJ; Halabi S
    J Clin Oncol; 2012 Sep; 30(27):3402-7. PubMed ID: 22891270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic role of pretreatment lactate dehydrogenase in patients with metastatic renal cell carcinoma: A systematic review and meta-analysis.
    Zhang N; Zhang H; Zhu D; JiRiGaLa ; Yu D; Wang C; WuYunBiLiGe ; Amin ; ZhiHong ; Yu H; Chen X; Wang M
    Int J Surg; 2020 Jul; 79():66-73. PubMed ID: 32417461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase.
    Koh YW; Lee SJ; Park SY
    Pathol Res Pract; 2017 Sep; 213(9):1134-1138. PubMed ID: 28756978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma.
    Shirotake S; Takamatsu K; Mizuno R; Kaneko GO; Nishimoto K; Oya M; Oyama M
    Anticancer Res; 2019 Aug; 39(8):4371-4377. PubMed ID: 31366532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative serum lactate dehydrogenase level predicts progression and prognosis in patients with glioma.
    Chen XY; Chen JY; Chen Y; Chen JF; Lin N; Ding CY; Kang DZ; Wang DL; Fang WH
    Clin Neurol Neurosurg; 2021 Oct; 209():106912. PubMed ID: 34509141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study.
    Auvray M; Elaidi R; Ozguroglu M; Guven S; Gauthier H; Culine S; Caty A; Dujardin C; Auclin E; Thibaut C; Combe P; Tartour E; Oudard S
    Clin Genitourin Cancer; 2017 Jun; 15(3):e469-e476. PubMed ID: 27964892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer.
    Blas L; Shiota M; Yamada S; Ieiri K; Nagakawa S; Tsukahara S; Matsumoto T; Kashiwagi E; Takeuchi A; Inokuchi J; Shiga KI; Yokomizo A; Eto M
    Anticancer Res; 2021 Aug; 41(8):3885-3889. PubMed ID: 34281850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.